DRKS00013900CompletedPhase 4
Validation and comparison of cervical lymph node staging after primary radio- or chemoradiotherapy of locoregionally advanced head and neck carcinomas - a prospective, multicenter study - HN-Onkoimage-1
Hals-Nasen-Ohrenklinik Universitätsmedizin Mainz0 sites40 target enrollmentStarted: November 5, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- N/a: Single Arm Study
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Initial diagnosis HNSCC UICC III / IV, incl. CUP syndrome with tumor board decision for primary radiotherapy or chemoradiotherapy (RCT) (planned 66-72Gy total dose) or radioimmunotherapy with cetuximab
- •- p16 status (immunohistochemistry) from the biopsy of the primary tumor or lymph node tissue
- •- Patient age at least 18 years
Exclusion Criteria
- •- Contrast allergy
- •- Palliative situation after completion of radiotherapy or chemoradiotherapy after tumor board consensus
- •- patient not eligible for ND
- •- Pregnancy / Breastfeeding
- •- non-consenting patient
- •- ECOG> 2 (Classification of the Eastern Cooperative Oncology Group)
Investigators
Similar Trials
Unknown
Not Applicable
Sentinel Lymph Node Mapping In Cervical CancerUterine Cervical NeoplasmsNCT03778268Peking University People's Hospital1,143
Completed
Not Applicable
Cervical lymph node involvement in dependence of tumor localization of oral squamos cell carcinoma - a retrospective studyC03C01C02C04C05C06C07Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthMalignant neoplasm of parotid glandDRKS00016654Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main150
Active, not recruiting
Phase 1
Identification of lymphatic metastasis in patients with parotid gland carcinoma by means of sentinel lymph node biopsy using 68-galium-tilmanocept PET-CT.The IMP will be used for the identification of sentinel lymph node(s) in patients with parotid gland carcinoma.MedDRA version: 21.1Level: LLTClassification code 10026329Term: Malignant neoplasm of parotid glandSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10072873Term: Sentinel lymph node mappingSystem Organ Class: 100000004848MedDRA version: 20.1Level: LLTClassification code 10073554Term: Sentinel node biopsySystem Organ Class: 100000004848EUCTR2021-003068-28-NLniversity Medical Center Utrecht10
Recruiting
Phase 3
Sentinel lymph node detection of cervical occult lymph node metastases in patients with parotid gland carcinoma by means of sentinel node biopsy using 68-galium-tilmanocept PET-CT.NL-OMON51066niversitair Medisch Centrum Utrecht10
Recruiting
Not Applicable
Multimodality Preoperative Evaluation of lymph nodes of perihilar cholangiocarcinoma – a pilot studyNL-OMON26687one10